Scaffold Therapeutics

📍 Boston, United States🗓 Founded 2022👥 3 employees💰 Last funded Jan 2022
Biotechnology Research🌐 scaffoldtx.com
Website LinkedIn
Scaffold Therapeutics is developing small-molecule oncology therapeutics targeting the m6A RNA methylation pathway. We are advancing a pipeline of assets, developing a library of novel screening compounds, and designing proprietary cellular assays that provide insight into m6A pathway biology.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2022
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Scaffold Therapeutics?
Scaffold Therapeutics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Scaffold Therapeutics last raise funding?
The most recent investment in Scaffold Therapeutics recorded on gritt.io was in January 2022.
When was Scaffold Therapeutics founded?
Scaffold Therapeutics was founded in 2022.
What industry is Scaffold Therapeutics in?
Scaffold Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Scaffold Therapeutics based?
Scaffold Therapeutics is headquartered in Boston, United States.